tiprankstipranks
Advertisement
Advertisement

HK:1244 Stock Latest News

3D Medicines Shareholders Approve All AGM Resolutions, Expand Capital Mandates
Company Announcements3D Medicines Shareholders Approve All AGM Resolutions, Expand Capital Mandates
11d ago
1244
3D Medicines consolidates company secretary and authorised representative roles
PremiumCompany Announcements
3D Medicines consolidates company secretary and authorised representative roles
11d ago
1244
3D Medicines Sets 2026 AGM to Approve Results, Board Changes and Share Mandate
PremiumCompany Announcements
3D Medicines Sets 2026 AGM to Approve Results, Board Changes and Share Mandate
1M ago
1244
3D Medicines’ Envafolimab Trial in Biliary Tract Cancer to Headline 2026 ASCO Meeting
PremiumCompany Announcements
3D Medicines’ Envafolimab Trial in Biliary Tract Cancer to Headline 2026 ASCO Meeting
2M ago
1244
3D Medicines Completes Phase III Envafolimab Lung Cancer Trial Enrollment Ahead of Schedule
PremiumCompany Announcements
3D Medicines Completes Phase III Envafolimab Lung Cancer Trial Enrollment Ahead of Schedule
2M ago
1244
3D Medicines Extends HK$50 Million Note to Puxin, Flags Disclosure Lapse
PremiumCompany Announcements3D Medicines Extends HK$50 Million Note to Puxin, Flags Disclosure Lapse
3M ago
1244
3D Medicines Advances Oncology Platforms Despite Envafolimab Revenue Dip in 2025
Premium
Company Announcements
3D Medicines Advances Oncology Platforms Despite Envafolimab Revenue Dip in 2025
3M ago
1244
3D Medicines Sets March 31 Board Meeting to Approve 2025 Results and Mull Dividend
Premium
Company Announcements
3D Medicines Sets March 31 Board Meeting to Approve 2025 Results and Mull Dividend
4M ago
1244
3D Medicines Moves Envafolimab Toward Full Approval in China
PremiumCompany Announcements
3D Medicines Moves Envafolimab Toward Full Approval in China
5M ago
1244
3D Medicines Appoints Veteran Capital Markets Executive as New CFO
PremiumCompany Announcements
3D Medicines Appoints Veteran Capital Markets Executive as New CFO
6M ago
1244
3D Medicines’ Envafolimab NDA for First-Line Biliary Tract Cancer Accepted by China’s NMPA
PremiumCompany Announcements
3D Medicines’ Envafolimab NDA for First-Line Biliary Tract Cancer Accepted by China’s NMPA
6M ago
1244
3D Medicines Wins Third Orphan-Drug Designation for Envafolimab in Gastric Cancers
PremiumCompany Announcements
3D Medicines Wins Third Orphan-Drug Designation for Envafolimab in Gastric Cancers
7M ago
1244
3D Medicines’ New Cancer Pain Study: Potential Market Impact
PremiumCompany Announcements3D Medicines’ New Cancer Pain Study: Potential Market Impact
9M ago
1244
3D Medicines Reports Strong Progress and Global Expansion in H1 2025
Premium
Company Announcements
3D Medicines Reports Strong Progress and Global Expansion in H1 2025
11M ago
1244
3D Medicines Administers First Dose of Novel Cancer Drug
Premium
Company Announcements
3D Medicines Administers First Dose of Novel Cancer Drug
11M ago
1244
3D Medicines Partners with CATUG Biotechnology to Enhance mRNA Therapy Development
PremiumCompany Announcements
3D Medicines Partners with CATUG Biotechnology to Enhance mRNA Therapy Development
11M ago
1244
3D Medicines Inc. Schedules Board Meeting for Interim Results and Dividend Consideration
PremiumCompany Announcements
3D Medicines Inc. Schedules Board Meeting for Interim Results and Dividend Consideration
11M ago
1244
3D Medicines Inc. Announces Withdrawal of Legal Proceedings
PremiumCompany Announcements
3D Medicines Inc. Announces Withdrawal of Legal Proceedings
12M ago
1244
3D Medicines Inc. Strengthens Stability with Strategic Agreement
PremiumCompany Announcements
3D Medicines Inc. Strengthens Stability with Strategic Agreement
12M ago
1244
3D Medicines, Inc. Enhances Operational Stability Through Strategic Cooperation
PremiumCompany Announcements3D Medicines, Inc. Enhances Operational Stability Through Strategic Cooperation
1y ago
1244
3D Medicines Inc. Announces Successful AGM Resolutions
Premium
Company Announcements
3D Medicines Inc. Announces Successful AGM Resolutions
1y ago
1244
3D Medicines Inc. Announces Board Composition and Committee Assignments
Premium
Company Announcements
3D Medicines Inc. Announces Board Composition and Committee Assignments
1y ago
1244

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >